Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Receivables - Affiliates (2016 - 2023)

Fortress Biotech (FBIO) has 8 years of Receivables - Affiliates data on record, last reported at $636000.0 in Q1 2023.

  • For Q1 2023, Receivables - Affiliates rose 0.79% year-over-year to $636000.0; the TTM value through Mar 2023 reached $636000.0, up 0.79%, while the annual FY2022 figure was $138000.0, 79.65% down from the prior year.
  • Receivables - Affiliates reached $636000.0 in Q1 2023 per FBIO's latest filing, up from $138000.0 in the prior quarter.
  • Across five years, Receivables - Affiliates topped out at $2.1 million in Q1 2019 and bottomed at $138000.0 in Q4 2022.
  • Average Receivables - Affiliates over 5 years is $924058.8, with a median of $849000.0 recorded in 2021.
  • The widest YoY moves for Receivables - Affiliates: up 200.24% in 2019, down 84.45% in 2019.
  • A 5-year view of Receivables - Affiliates shows it stood at $865000.0 in 2019, then fell by 13.99% to $744000.0 in 2020, then fell by 8.87% to $678000.0 in 2021, then tumbled by 79.65% to $138000.0 in 2022, then surged by 360.87% to $636000.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Affiliates were $636000.0 in Q1 2023, $138000.0 in Q4 2022, and $153000.0 in Q3 2022.